Eversana expanded its AI commercialization platform with new medical affairs and commercial capabilities, adding modules aimed at streamlining medical information workflows, market research support, and MLR automation. The company said its agentic AI orchestration and workflow automation stack is now being applied beyond marketing operations into broader commercialization functions. Chief Executive Officer Mark Thierer framed the expansion as a shift from isolated pilots toward scalable deployments, emphasizing governance and compliance requirements in pharma commercialization. New offerings include medical information support, analytics for commercial teams, and workflow capabilities intended to accelerate content development and knowledge reuse across field-facing work. For biotech and pharma operators, this update matters because it moves AI adoption toward regulated, customer-facing workstreams where content accuracy, traceability, and policy alignment are central.